Canopy Growth (CGC) Assets Average (2019 - 2026)
Canopy Growth (CGC) posted Assets Average of $804.5 million for Q1 2026, up 2.45% sequentially from $785.3 million in Q4 2025, and up 9.24% YoY from $736.5 million in Q1 2025.
Canopy Growth (CGC) Assets Average (2019 - 2026) Analysis & Trends
Canopy Growth has reported Assets Average for 8 years, with the latest figure at $804.5 million in Q1 2026.
- Quarterly Assets Average rose 9.24% year-over-year to $804.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $804.5 million (up 9.24% YoY) and the FY2026 annual result came in at $804.5 million, changed 0.28% from the prior year.
- Assets Average grew to $804.5 million in Q1 2026 per CGC's latest filing, from $785.3 million in the prior quarter.
- Over five years, Assets Average peaked at $4.7 billion in Q1 2022 and troughed at $646.2 million in Q2 2025.
- A 5-year average of $1.6 billion and a median of $981.9 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2023 and 2026: Assets Average plunged 57.9% in 2023, then advanced 9.24% in 2026.
- Over 5 years, Assets Average stood at $2.4 billion in 2022, then tumbled by 52.38% to $1.1 billion in 2023, then slipped by 22.57% to $868.4 million in 2024, then fell by 9.57% to $785.3 million in 2025, then increased by 2.45% to $804.5 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $804.5 million, $785.3 million, and $715.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 806.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 806.92 Mn |
| Mar 31, 2026 | 804.51 Mn |
| Dec 31, 2025 | 785.31 Mn |
| Sep 30, 2025 | 715.15 Mn |
| Jun 30, 2025 | 646.24 Mn |
| Mar 31, 2025 | 736.48 Mn |
| Dec 31, 2024 | 868.39 Mn |
| Sep 30, 2024 | 921.90 Mn |
| Jun 30, 2024 | 952.70 Mn |
| Mar 31, 2024 | 981.89 Mn |
| Dec 31, 2023 | 1.12 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 1.99 Bn |
| Dec 31, 2022 | 2.36 Bn |
| Sep 30, 2022 | 2.65 Bn |
| Jun 30, 2022 | 3.59 Bn |
| Mar 31, 2022 | 4.72 Bn |
| Dec 31, 2021 | 5.08 Bn |
| Sep 30, 2021 | 5.41 Bn |